USA — Agency Chief Outlines Threat Reduction Strategy

WASHINGTON, Feb. 23, 2011 — The Defense Threat Reduc­tion Agency is at work around the clock to pro­tect Amer­i­can forces and cit­i­zens from nuclear, chem­i­cal and bio­log­i­cal threats, the agency’s direc­tor said today.
Speak­ing to the Defense Writ­ers Group, Ken­neth A. Myers III, who also is direc­tor of the U.S. Strate­gic Com­mand Cen­ter for Com­bat­ing Weapons of Mass Destruc­tion, said the “lines of defense” strat­e­gy aims to detect, inter­dict and defend against weapons of mass destruc­tion.

“How do we make it hard­er, how do we cre­ate more lines of defense between the threats and the Amer­i­can peo­ple?” he asked. 

The val­ue and effec­tive­ness of coun­ter­ing any threat from weapons of mass destruc­tion is much greater at the source, Myers said. 

“The first line of defense is at the source. The sec­ond line is detec­tion [and] inter­dic­tion of these threats before they reach the Amer­i­can peo­ple,” he said. “But the oth­er major part of the DTRA respon­si­bil­i­ty is that last line of defense, here at home, and that’s con­se­quence management.” 

In the nuclear are­na, one task his agency per­forms is nuclear inspec­tions. With the New Strate­gic Arms Reduc­tion Treaty now in force, Myers said, his peo­ple are trained and ready to take on the inspec­tion duties it authorizes. 

Car­ry­ing out nuclear weapons inspec­tions in Rus­sia is a ver­i­fi­ca­tion mis­sion, Myers explained, adding that his agency’s teams also will escort Russ­ian teams on their inspec­tions in the Unit­ed States. 

“It’s a mis­sion that we’ve had for a num­ber of years,” he said. “It is one that we’re con­stant­ly trained for.” 

In recent months that train­ing has inten­si­fied, Myers said, as inspec­tors pre­pare to ver­i­fy stock­piles of Russ­ian nuclear weapons. 

“We’ve been involved with this treaty for quite some time,” Myers said. “We’ve under­stood from the begin­ning of the process what would be required, … [and] we’re ready to go.” New START pro­vides for few­er inspec­tions than the pre­vi­ous START treaty, he said, in part because the new treaty com­bines some types of inspec­tions, and also because “we’re talk­ing about few­er weapons. The num­bers are com­ing down.” 

Judg­ments on treaty com­pli­ance are not part of his agency’s mis­sion, the direc­tor said. “We are the inspec­tors — we don’t make ver­i­fi­ca­tion judg­ments,” he said. “We report the facts. Judg­ments on com­pli­ance are made by oth­er members.” 

His agency’s inspec­tors, Myers said, are the best in the world. “I’m con­fi­dent we’ll get all the infor­ma­tion we need,” he added. 

While the first inspec­tions have not been sched­uled, he said, teams are “wait­ing for the call.” 

In con­trast to the ver­i­fi­ca­tion mis­sion his agency will per­form under the new START, much of the threat reduc­tion effort focus­es on find­ing and coun­ter­ing risks involv­ing weapons of mass destruc­tion, Myers said. His agency is respon­si­ble for much of the sci­ence and tech­nol­o­gy devel­op­ment in coun­ter­ing chem­i­cal and bio­log­i­cal weapons, he explained, and also is the banker for chem­i­cal and bio­log­i­cal defense funds. 

The threat is diverse, and coun­ter­mea­sure devel­op­ment is spread across a range of efforts, Myers said. 

He explained that whether a threat involves sam­ples of harm­ful virus­es or stock­piles of fis­sion­able mate­ri­als, his agency aims to build as many walls as pos­si­ble between that threat and Amer­i­can cit­i­zens and ser­vice members. 

For exam­ple, in coun­ter­ing bio­log­i­cal weapons, the agency works both to con­tain the pos­si­ble spread of dis­ease agents, and also to devel­op vac­cines against those dis­eases, he said, adding that the Ebo­la and Mar­burg virus­es are an area in which the agency has seen “first-lev­el success.” 

It may take 15 to 20 years for the phar­ma­ceu­ti­cal indus­try to devel­op an effec­tive drug to mit­i­gate a threat, he said. “Our No. 1 goal is to short­en these time­frames — that is, to try to get solu­tions to the warfight­er … and the Amer­i­can peo­ple, should we face these types of threats,” he said. 

The poten­tial for bio­log­i­cal or nuclear weapons to be used against U.S. cit­i­zens spurs his agency to move quick­ly in putting defens­es in place, Myers said. 

“Our strat­e­gy is to cut the time­lines, to move faster,” he said. “At the end of the day, you have a threat, and you have a solu­tion. Try­ing to match them up as quick­ly as pos­si­ble is the challenge.” 

The Ebo­la virus, which occurs nat­u­ral­ly in sub-Saha­ran Africa, may be as great a threat as a man­made weapon else­where, Myers point­ed out. 

“It’s hard for me to tell you that a bio­log­i­cal weapon or a vir­u­lent dis­ease is not a threat,” he said. “They’re all threats. A lot of the [rel­a­tive risk involves] the like­li­hood of find­ing them in nature, and the ease or com­plex nature of manip­u­lat­ing them.” 

Many health facil­i­ties in Africa store sam­ples of dis­eases that occur nat­u­ral­ly in the region, he said, not­ing such facil­i­ties often are close to areas that may be ter­ror­ist recruit­ing or oper­at­ing grounds. 

The Defense Threat Reduc­tion Agency devel­ops tools for the ser­vices to use in coun­ter­ing weapons of mass destruc­tion, Myers said, cit­ing the “mas­sive ord­nance pen­e­tra­tor,” a weapon the agency fund­ed, test­ed, found effec­tive, then hand­ed off to the Air Force. The weapon is designed to attack hard­ened con­crete bunkers and tun­nels, where weapons of mass destruc­tion com­po­nents may be stored, he explained. 

“The goal is to hold deeply buried tar­gets and oth­er poten­tial threats … at risk. … I think we’ve proven we can hold deeply buried tar­gets at risk,” Myers said. “We want to work to change the behav­ior, change the efforts by some to use facil­i­ties to devel­op weapons of mass destruction.” 

The fact that the Unit­ed States has not suf­fered a seri­ous bio­log­i­cal or nuclear attack is sig­nif­i­cant, though the threat remains real, Myers said. 

“I go to work every day with 2,000 peo­ple whose job is to stop that from hap­pen­ing,” he said. 

Agency pro­grams focus on devel­op­ing tools and strate­gies to detect, inter­dict and counter weapons of mass destruc­tion, he said, in line with the president’s focus on defend­ing against nuclear and bio­log­i­cal threats. 

“I believe that the poli­cies [and] the pro­grams that we have in place are mak­ing a big dif­fer­ence,” Myers said. “I think the peo­ple [and] the skill sets that we have focused on this prob­lem are mak­ing a big difference.” 

One thing that makes the agency effec­tive, the direc­tor said, is that it has both a research and devel­op­ment arm and a full oper­a­tions side. 

“You walk down the hall­way and you have a nuclear physi­cist, a micro­bi­ol­o­gist, and a for­mer Spe­cial Forces oper­a­tor sit­ting there talk­ing togeth­er, try­ing to solve prob­lems,” he said. “It real­ly is a very unique institution.” 

His agency’s part­ners in defend­ing against weapons of mass destruc­tion include the mil­i­tary ser­vices, the Depart­ment of Home­land Secu­ri­ty, the Nation­al Secu­ri­ty Agency, the Cen­ters for Dis­ease Con­trol and Pre­ven­tion, and embassies around the world, Myers said. 

“To pro­tect the Amer­i­can peo­ple, we need to devel­op as many lines of defense as pos­si­ble,” he said. 

U.S. Depart­ment of Defense
Office of the Assis­tant Sec­re­tary of Defense (Pub­lic Affairs) 

Face­book and/or on Twit­ter

Team GlobDef

Seit 2001 ist im Internet unterwegs, um mit eigenen Analysen, interessanten Kooperationen und umfassenden Informationen für einen spannenden Überblick der Weltlage zu sorgen. war dabei die erste deutschsprachige Internetseite, die mit dem Schwerpunkt Sicherheitspolitik außerhalb von Hochschulen oder Instituten aufgetreten ist.

Alle Beiträge ansehen von Team GlobDef →